From the Dietary Supplement Information Bureau
GlaxoSmithKline, the second-largest pharmaceutical company in the world and makers of many prescription and over-the-counter drugs has petitioned the FDA to classify weight loss claims for dietary supplements as ‘disease claims’. Many believe that this is an effort by GlaxoSmithKline, makers of alli™, an over-the-counter weight loss drug, to quash competition from the dietary supplement weight loss industry…